Intuitive Surgical Inc (ISRG)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA and an Investment Account

Sell

$522.59

Buy

$532.00

arrow-up$12.24 (+2.37%)

Prices updated at 02 May 2025, 21:38 EDT

Prices minimum 15 mins delay

Prices in USD

Intuitive Surgical Inc designs, manufactures, markets da Vinci Surgical Systems, and related instruments. The da Vinci surgery, combines the benefits of minimally invasive surgery for patients with the ease of use, precision and dexterity of open surgery.

NASDAQ

1.51%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Chairman

Dr. Craig H. Barratt,PhD

CEO

Dr. Gary S. Guthart,PhD

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

15,638

Head office

1020 Kifer Road

Sunnyvale

United States

94086-5304

+1 408 523-2100

investor.relations@intusurg.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Jamie E. Samath Executive Vice President, Chief Financial Officer and Head, Business Technology	0.60m
Mr. Henry L. Charlton Executive Vice President, Chief Commercial and Marketing Officer	0.60m
Ms. Amal M. Johnson Independent Director	0.09m
Dr. Craig H. Barratt,PhD Chairman of the Board	0.08m
Dr. Gary S. Guthart,PhD Director and Chief Executive Officer	1.01m
Ms. Jami Dover Nachtsheim Independent Director	0.09m
Mr. Mark J. Rubash Independent Director	0.09m
Mr. Lewis Chew Independent Director	0.06m
Mr. Keith R. Leonard, Jr Independent Director	0.08m
Mr. Joseph C. Beery Independent Director	0.08m
Mr. David J. Rosa President and Director	0.75m
Mr. Gary H. Loeb Executive Vice President, Chief Legal Officerand Chief Compliance Officer	-
Dr. Myriam J. Curet, F.A.C.S.,M.D. Executive Vice President and Chief Medical Officer	-
Ms. Sreelakshmi Kolli Independent Director	0.08m
Mr. Robert DeSantis Executive Vice President and Chief Strategy and Corporate Operations Officer	-
Dr. Amy L. Ladd, M.D. Independent Director	0.08m
Dr. Monica P. Reed, M.D. Independent Director	0.08m
Mr. Fredrik C. Widman Principal Accounting Officer, Vice President and Corporate Controller	-
Mr. Mark P. Brosius Senior Vice President and Chief Manufacturing and Supply Chain Officer	-
Dr. Brian E. Miller, PhD Executive Vice President and Chief Digital Officer	0.55m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	32,212,196
BlackRock Inc	31,377,331
State Street Corp	15,305,425
T. Rowe Price Associates, Inc.	14,469,612
Fidelity Management & Research Company LLC	12,743,081

Director dealings

Date chevron-l-regular chevron-r-regular	Action
10 Dec 2024	-
10 Dec 2024	-
10 Dec 2024	-
10 Dec 2024	-
10 Dec 2024	-
10 Dec 2024	-
29 Nov 2024	-
29 Nov 2024	-
29 Nov 2024	-
29 Nov 2024	-
29 Nov 2024	-
29 Nov 2024	-
29 Nov 2024	-
29 Nov 2024	-
29 Nov 2024	-
29 Nov 2024	-
29 Nov 2024	-
29 Nov 2024	-
26 Nov 2024	-
26 Nov 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.